MDxHealth S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MDxHealth S.A. with three other
miscellaneous service companies in Europe:
sales of 23.82 million Swiss Francs [US$24.33 million]
of which 100%
was Discovering,Developing and Commercializi),
(20.57 million Euros [US$22.19 million]
Molecular Partners AG
based in SWITZERLAND
(20.38 million Swiss Francs [US$20.82 million]
MDxHealth S.A. reported sales of 19.56 million Euro (US$21.10 million)
December of 2019.
decrease of 18.8%
versus 2018, when the company's sales were 24.10 million Euro.